Skip to content

Feasibility and Acceptability Study of My Sleep Our Sleep (MSOS) Program

Feasibility and Acceptability Study of My Sleep Our Sleep (MSOS) Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04712604
Enrollment
26
Registered
2021-01-15
Start date
2021-03-14
Completion date
2022-01-25
Last updated
2022-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Keywords

Sleep disturbance in GI cancer patients and their sleep partner

Brief summary

The purpose of this study is to test feasibility and acceptability of a psycho-behavioral intervention on sleep in cancer patients and their partners.

Interventions

MSOS Program is a weekly one-hour Zoom session that focuses on psychoeducation on sleep health for both patients and their sleep partners.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patients: 1. newly diagnosed with a gastrointestinal cancer (stage I to IV) 12 months or less prior to participating 2. 18 years or older 3. able to speak/read English at the 5th grade level 4. having a consistent partner who is involved in daily activities including sleep 5. having 5 or greater score on the Pittsburgh Sleep Quality Index. Sleep partners: 1. 18 years or older 2. able to speak/read English at the 5th grade level 3. a partner of the patient who is involved in the patient's daily activities including sleep 4. having similar circadian rhythm/sleep patterns with the patient 5. having 5 or greater score on the Pittsburgh Sleep Quality Index.

Exclusion criteria

Patients and their sleep partners: 1. having had a diagnosis of dementia, psychotic disorder, major depressive disorder, bipolar disorder, which currently has not been treated 2. having active suicidality in the past year 3. currently having an untreated diagnosed sleep disorder (narcolepsy, restless leg syndrome) 4. currently having have a poor physical functioning status as measured by an Eastern Cooperative Oncology Group (ECOG) score of 3 or higher and Karnofsky grade of 50 or lower 5. having poor cognitive function status as measured by the Mini Mental State Examination score of 24 or less 6. unable to see or hear 7. at the end of life (life expectancy of less than a month) 8. unwilling to change their current sleep-related habits in near future.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the intervention4 weeksFeasibility of the intervention will be reported as the percentage of participants who enroll and complete all the sessions of the study.
Acceptability of the intervention4 weeksAcceptability of the intervention will be reported as the percentage of participants who evaluated the intervention and the interventionist as satisfactory or better.

Secondary

MeasureTime frameDescription
Change in sleep disturbanceBaseline, 4 weeksChange in sleep disturbance as measured by the Pittsburgh Sleep Quality Index (PSQI). PSQI has a total score ranging from 0 to 21, where lower score indicates healthier sleep quality.
Change in quality of lifeBaseline, 4 weeksChange in quality of life as measured by the Patient-reported Outcomes Measurement Information System (PROMIS-29). PROMIS-29 has a total score ranging from 20-80, with lower scores indicating better quality of life.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026